Tg Therapeutics (TGTX) Finished Goods (2023 - 2025)

Tg Therapeutics' Finished Goods history runs 3 years deep, the most recent figure standing at $21.1 million for Q3 2025.

• On a quarterly basis, Finished Goods rose 164.86% year-over-year to $21.1 million in Q3 2025; TTM through Sep 2025 was $21.1 million, a 164.86% increase from a year earlier, with the FY2024 full-year figure at $13.9 million, up 597.25% from the prior year.
• Finished Goods slipped to $21.1 million in Q3 2025 per TGTX's latest filing, from $21.8 million in the prior quarter.
• Across five years, Finished Goods topped out at $21.8 million in Q2 2025 and bottomed at $52000.0 in Q1 2023.
• The 3-year median for Finished Goods is $2.0 million (2023), against an average of $7.5 million.
• Biggest YoY gain for Finished Goods was 3559.62% in 2024; the steepest drop was 145.07% in 2024.
• Year by year, Finished Goods stood at $2.0 million in 2023, then jumped by 597.25% to $13.9 million in 2024, then soared by 51.3% to $21.1 million in 2025.
• Per Business Quant, the three latest TGTX Finished Goods figures stand at $21.1 million (Q3 2025), $21.8 million (Q2 2025), and $10.7 million (Q1 2025).